Fortress Biotech, Inc. (FBIO) Free cash flow 2016–2024
Fortress Biotech, Inc. (FBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$80.2MFY2024 · since FY2016: -$52.2M → -$80.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$80.2M | +37.5% |
| FY2023 | -$128.3M | +29.6% |
| FY2022 | -$182.1M | -50.4% |
| FY2021 | -$121.1M | -41.5% |
| FY2020 | -$85.6M | +12.0% |
| FY2019 | -$97.3M | +8.1% |
| FY2018 | -$105.9M | -29.3% |
| FY2017 | -$82.0M | -57.1% |
| FY2016 | -$52.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice